Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT4 receptor and its consequences in early BALB/c mouse embryonic development
2007

Maternal Autoantibodies and Fetal Development in Mice

Sample size: 15 publication Evidence: moderate

Author Information

Author(s): Kamel Rehab, Garcia Simone, Lezoualc'h Frank, Fischmeister Rodolphe, Muller Sylviane, Hoebee Johan, Eftekhari Pierre

Primary Institution: CNRS UPR 9021 Immunologie et Chimie Thérapeutiques Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France

Hypothesis

The study investigates the role of maternal autoantibodies against the serotoninergic 5-HT4 receptor in fetal development.

Conclusion

Maternal anti-5-HT4 receptor autoantibodies negatively impact fetal development in BALB/c mice.

Supporting Evidence

  • 5-HT4 receptor mRNA increased in the brain from 12th gestation day to 1 day postnatal.
  • Maternal antibodies led to decreased number of embryos and various developmental abnormalities.
  • Control mice gave birth to a normal number of pups, while immunized mice had significantly fewer.

Takeaway

Moms' antibodies can hurt baby mice's hearts and growth before they're born.

Methodology

The study involved immunizing female BALB/c mice with peptides to induce antibodies, followed by monitoring fetal development and abnormalities.

Limitations

The study is limited to a specific mouse model and may not fully represent human conditions.

Participant Demographics

Female BALB/c mice were used in the study.

Digital Object Identifier (DOI)

10.1186/1471-213X-7-34

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication